Preferred Label : exforge HCT;
MeSH note : Antihypertensive; a fixed dose combination of Amlodipine/valsartan/hydrochlorothiazide;
Is substance : O;
Origin ID : C547693;
UMLS CUI : C2701249;
ATC code(s)
- CISMeF manual mappings
- MeSH term(s) associated for indexing
- Record concept(s)
- Semantic type(s)
https://www.ema.europa.eu/medicines/human/EPAR/Exforge-HCT
2012
false
United Kingdom
French
English
syndication feed
Valsartan
Valsartan
drug labeling
treatment outcome
drug approval
administration, oral
adult
aged
diuretics
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
angiotensin II type 1 receptor blockers
amlodipine
antihypertensive agents
sodium chloride symporter inhibitors
hydrochlorothiazide
amlodipine
antihypertensive agents
sodium chloride symporter inhibitors
calcium channel blockers
diuretics
hydrochlorothiazide
angiotensin II type 1 receptor blockers
calcium channel blockers
drug combinations
valsartan, amlodipine and hydrochlorothiazide
exforge HCT
Amlodipine Besylate
summary of product characteristics
package leaflet
drug evaluation
---
http://www.has-sante.fr/portail/jcms/c_1294042/exforge-hct-synthese-28032012
http://www.has-sante.fr/portail/jcms/c_1251529/exforge-hct-28032012-avis-ct11985
http://www.has-sante.fr/portail/jcms/c_1294106/exforge-hct-association-fixe-amlodipine/valsartan/hydrochlorothiazide
2012
false
France
French
evaluation of the transparency committee
guidelines for drug use
Valsartan
antihypertensive agents
diuretics
hypertension
valsartan, amlodipine and hydrochlorothiazide
Amlodipine Besylate
adult
aged
randomized controlled trials as topic
diastolic pressure
systolic pressure
blood pressure
hydrochlorothiazide
exforge HCT
drug combinations
administration, oral
insurance, health, reimbursement
treatment outcome
amlodipine
comparative study
---
http://www.has-sante.fr/portail/jcms/c_944504/exforge-hct
http://www.has-sante.fr/portail/jcms/c_1250041/exforge-hct
2012
false
France
French
evaluation of the transparency committee
Valsartan
exforge HCT
drug combinations
administration, oral
insurance, health, reimbursement
hydrochlorothiazide
amlodipine
Amlodipine Besylate
valsartan, amlodipine and hydrochlorothiazide
hypertension
adult
aged
treatment outcome
clinical trials, phase iii as topic
antihypertensive agents
---
http://www.has-sante.fr/portail/upload/docs/application/pdf/2010-04/exforge_hct-_ct-7151.pdf
http://www.has-sante.fr/portail/jcms/c_966568/exforge-hct-association-fixe-damlodipine/valsartan/hydrochlorothiazide-antihypertenseur
2010
false
France
French
Valsartan
drug combinations
amlodipine
hydrochlorothiazide
administration, oral
insurance, health, reimbursement
valsartan, amlodipine and hydrochlorothiazide
hypertension
adult
treatment outcome
antihypertensive agents
exforge HCT
Amlodipine Besylate
evaluation of the transparency committee
guidelines for drug use
---
